Ketamine at the Center of Cornell 7 Case: What You Need to Know

New York prosecutors reopens investigation into ketamine-facilitated sexual assault allegations at Cornell University. Learn about the drug's legal status an...

Editorial Desk

October 2, 2026 One Min Read

POLICY WIRE — New York, United States — New York prosecutors have launched a fresh probe into claims that a former Cornell University student was drugged and sexually assaulted by seven fraternity members in 2024.

The woman alleges in a lawsuit that she was pressured to snort a white powder believed to be ketamine during the incident. The drug, approved for medical use, is also known for its hallucinogenic effects and has been linked to recreational abuse and sexual assault cases.

📄 POLICY WIRE WHITEPAPER PUBLISHED: PAKISTAN’S NATIONAL SECURITY POLICY PRIORITIES

👉 READ BY CLICKING HERE

Ketamine, a dissociative anesthetic, is used in veterinary care and human medicine for depression and sedation. However, it is classified as a Schedule III controlled substance due to its potential for misuse. Recent federal data shows a 40% increase in recreational use between 2021 and 2022. The case has reignited national discussions on campus safety and the role of fraternities in sexual misconduct.

Reporting by Policy-Wire (PW)

Author

Editorial Desk

Policy Wire is your go-to editorial hub for insightful perspectives and informed analysis on pressing policy issues, both regionally and globally. Over the years, Policy Wire has collaborated with leading international news agencies—including AFP, AP, Reuters, and others—to provide fact-based reporting and nuanced commentary. With a commitment to clarity and credibility, we aim to bridge the gap between complex policy debates and public understanding, ensuring that our readers stay informed on the issues shaping the world today.